BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26975372)

  • 1. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
    Willard FS; Ho JD; Sloop KW
    Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
    Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
    Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor.
    Eng H; Sharma R; McDonald TS; Edmonds DJ; Fortin JP; Li X; Stevens BD; Griffith DA; Limberakis C; Nolte WM; Price DA; Jackson M; Kalgutkar AS
    Drug Metab Dispos; 2013 Aug; 41(8):1470-9. PubMed ID: 23653442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
    Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
    Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.
    Sloop KW; Willard FS; Brenner MB; Ficorilli J; Valasek K; Showalter AD; Farb TB; Cao JX; Cox AL; Michael MD; Gutierrez Sanfeliciano SM; Tebbe MJ; Coghlan MJ
    Diabetes; 2010 Dec; 59(12):3099-107. PubMed ID: 20823098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.
    Nolte WM; Fortin JP; Stevens BD; Aspnes GE; Griffith DA; Hoth LR; Ruggeri RB; Mathiowetz AM; Limberakis C; Hepworth D; Carpino PA
    Nat Chem Biol; 2014 Aug; 10(8):629-31. PubMed ID: 24997604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
    Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
    Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
    Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
    J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Secretion Depends on Intra-islet Glucagon Signaling.
    Svendsen B; Larsen O; Gabe MBN; Christiansen CB; Rosenkilde MM; Drucker DJ; Holst JJ
    Cell Rep; 2018 Oct; 25(5):1127-1134.e2. PubMed ID: 30380405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Méndez M; Matter H; Defossa E; Kurz M; Lebreton S; Li Z; Lohmann M; Löhn M; Mors H; Podeschwa M; Rackelmann N; Riedel J; Safar P; Thorpe DS; Schäfer M; Weitz D; Breitschopf K
    J Med Chem; 2020 Mar; 63(5):2292-2307. PubMed ID: 31596080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels.
    Zhang Y; Ding Y; Zhong X; Guo Q; Wang H; Gao J; Bai T; Ren L; Guo Y; Jiao X; Liu Y
    Mol Cell Endocrinol; 2016 Jul; 430():89-96. PubMed ID: 27126219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.